ABO (rs657152) was first described as a genetic susceptibility locus in patients with COVID-19 with respiratory failure suggesting a potential involvement also for the ABO blood group system, showing a higher risk in blood group A and a protective effect in blood group O as compared with other groups (Severe Covid et al., 2020; Venkataraman et al., 2022). The gene discussed is ABO; the disease is respiratory failure.